Richard Libby, RPH | |
160 Paine Tpke N, Berlin, VT 05602-8293 | |
(802) 223-8599 | |
(802) 223-8598 |
Full Name | Richard Libby |
---|---|
Gender | Male |
Speciality | Pharmacist |
Location | 160 Paine Tpke N, Berlin, Vermont |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1679934947 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | 033.0099538 (Vermont) | Primary |
Mailing Address | Practice Location Address |
---|---|
Richard Libby, RPH 160 Paine Tpke N, Berlin, VT 05602-8293 Ph: (802) 223-8599 | Richard Libby, RPH 160 Paine Tpke N, Berlin, VT 05602-8293 Ph: (802) 223-8599 |
News Archive
A new study from researchers at the Keck School of Medicine of the University of Southern California (USC) shows that treadmill exercises may benefit patients with Parkinson's Disease and those with similar movement disorders.
A multi-institution team of investigators led by researchers at the Keck School of Medicine of the University of Southern California (USC) has received $19 million in funding from the National Institutes of Mental Health (NIMH) for a groundbreaking effort to collect genetic information on tens of thousands of patients in order to study the genetic risks for schizophrenia and bipolar disorder.
Existing techniques for predicting premature birth are inadequate or invasive - with risks and discomfort. Researcher Chiara Rabotti (Eindhoven University of Technology) developed a new measuring method, based on a rather simple electrode plaster that is attached to the abdomen. In the future every pregnant woman can thereby calmly await the moment, Rabotti expects.
Pharnext SAS, a biopharmaceutical company specializing in the development of innovative treatments for severe neurological diseases and other major unmet medical needs, today announced that the French Agency for Healthcare Product Safety (AFSSAPS) has authorized a Phase II clinical trial with the first drug (a Pleodrug™) generated by the company's Pleotherapy™ technology platform in patients suffering from Charcot-Marie Tooth disease type 1A (CMT1A.
What sounds like science fiction is actually possible: thanks to magnetic stimulation, the activity of certain brain nerve cells can be deliberately influenced. What happens in the brain in this context has been unclear up to now. Medical experts from Bochum under the leadership of Prof. Dr. Klaus Funke (Department of Neurophysiology) have now shown that various stimulus patterns changed the activity of distinct neuronal cell types.
› Verified 8 days ago
Silene R Barberi, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 282 Berlin Mall Rd, Berlin, VT 05602 Phone: 802-229-8049 Fax: 802-229-8047 | |
Dr. Marc Allen Semprebon, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 350 Fisher Road, Vermont Psychiatric Care Hospital, Berlin, VT 05602 Phone: 802-828-3092 Fax: 802-828-2588 | |
Mr. Denis Daigneault, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 160 Paine Tpke N, Berlin, VT 05602 Phone: 802-223-8599 | |
Elkanah Linder, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 282 Berlin Mall Rd Ste 1, Berlin, VT 05602 Phone: 802-229-8049 |